De novo anti-type VII collagen antibodies in patients with recessive dystrophic epidermolysis bullosa

Journal of Investigative Dermatology

Volumn 134, Issue 4, 2014, Pages 1138-1140

  Woodley, David T ^a   Cogan, Jon ^a   Wang, Xinyi ^a   Hou, Yingping ^a   Haghighian, Cyrus ^a   Kudo, Gail ^a   Keene, Douglas R ^b   Chen, Mei ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b SHRINERS HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; COLLAGEN ANTIBODY; COLLAGEN TYPE 7; GLYCINE; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; EPIDERMOLYSIS BULLOSA DYSTROPHICA; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LETTER; MIDDLE AGED; MISSENSE MUTATION; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN FRAGILITY; TRANSMISSION ELECTRON MICROSCOPY; YOUNG ADULT;

ADULT; ALLELES; ANTIBODIES; CHILD; CHILD, PRESCHOOL; COLLAGEN TYPE VII; DNA MUTATIONAL ANALYSIS; EPIDERMOLYSIS BULLOSA DYSTROPHICA; GENE EXPRESSION REGULATION; GENES, RECESSIVE; HUMANS; MIDDLE AGED; MUTATION; PROTEIN STRUCTURE, TERTIARY; SKIN; YOUNG ADULT;

EID: 84897045394     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.475     Document Type: Letter

References (14)

1. Burgeson RE (1993) Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 101:252-5
2. Chen M, Kasahara N, Keene DR et al. (2002) Restoration of type VII collagen expression and function in dystrophic epidermolysis bul-losa. Nat Genet 32:670-5
3. Chen M, Petersen MJ, Li HL et al. (1997) Ultraviolet A irradiation upregulates type VII collagen expression in human dermal fibroblasts. J Invest Dermatol 108:125-8
4. Fine JD, Eady RA, Bauer EA et al. (2008) The Classification of inherited epidermolysis bul-losa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58:931-50
5. Pendaries V, Gasc G, Titeux M et al. (2010) Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epider-molysis bullosa. Gene Therapy 17:930-7
6. Remington J, Wang X, Hou Y et al. (2009) Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dys-trophic epidermolysis bullosa. Mol Ther 17:26-33
7. Tampoia M, Bonamonte D, Filoni A et al. (2013) Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epider-molysis bullosa. Orphanet J Rare Dis 8:132
8. Wagner JE, Ishida-Yamamoto A, McGrath JA et al. (2010) Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 363:629-39
9. Wertheim-Tysarowska K, Sobczyska-Tomaszewska A, Kowalewski C et al. (2012) The COL7A1 mutation database. Hum Mutat 33:327-31
10. Wong T, Gammon L, Liu L et al. (2008) Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128:2179-89
11. Woodley DT, Briggaman RA, O'Keefe EJ et al. (1984) Identification of the skin basement-membrane autoantigen in epidermolysis bul-losa acquisita. N Engl J Med 310:1007-13
12. Woodley DT, Keene DR, Atha T et al. (2004a) Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat Med 10:693-5
13. Woodley DT, Keene DR, Atha T et al. (2004b) Intra-dermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo. Mol Ther 10:318-26
14. Yaoita H, Briggaman RA, Lawley TJ et al. (1981) Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 76:288-92